A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Danila, D. C.; Waterhouse, D. M.; Appleman, L. J.; Pook, D. W.; Matsubara, N.; Dorff, T. B.; Lee, J. L.; Armstrong, A. J.; Kim, M.; Horvath, L.; Sumey, C. J.; Cooner, F.; Salvati, M.; Stieglmaier, J.; Kelly, W. K. |
| Abstract Title: | A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304982 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS5101 |
| Notes: | Meeting Abstract: TPS5101 -- This meeting was also held virtually -- Source: Wos |
